EGFR and non-small cell lung carcinoma: Nonetheless, only this evidence is not enough to draw a strong conclusion; hence further investigation will be needed to clearly demonstrate the specific mechanism of Flot-2 and EGFR in NSCLC, and that’s what we’re about to study in the near future.